Table 1.
Baseline characteristics of the study cohort (n = 27).
| n (%) | ||
|---|---|---|
| Median age (range) | 64 (42–92) | |
| Gender | Male | 19 (70) |
| Female | 8 (30) | |
| ECOG PS | 0 | 6 (22) |
| 1 | 9 (33) | |
| 2/3 | 9 (33) | |
| Unknown | 3 (11) | |
| Race | Caucasian | 18 (67) |
| African American | 9 (33) | |
| Histology | Clear cell | 15 (56) |
| Papillary | 7 (26) | |
| Unclassified | 3 (11) | |
| Chromophobe | 1 (4) | |
| Translocation | 1 (4) | |
| IMDC risk | Intermediate | 23 (85) |
| Poor | 4 (15) | |
| IMDC risk factors | ||
| 1 | 9 (33) | |
| 2 | 14 (15) | |
| 3 | 4 (15) | |
| Nephrectomy | Yes | 19 (70) |
| No | 8 (30) | |
| Location of metastases (>5%) | Lung | 16 (59) |
| Lymph node | 11 (41) | |
| Brain | 5 (19) | |
| Adrenal gland | 3 (11) | |
| Liver | 3 (11) | |
| Peritoneum | 3 (11) | |
| Bone | 2 (7) |
LLN, lower limit of normal; ULN, upper limit of normal.